quarter of Year 2019 and 2020 were in amounts of Baht 172.23 million and Baht 212.13 million, respectively, which increased by Baht 39.90 million or in the proportion of 23.2%. These changes were stemmed
Baht per share, the disposal value of Baht 115 million, and the Company was paid for the disposal of such share proportion on August 15, 2017, resulting in the change of the Company’s shareholding
proportion of selling expenses incurred compared to total revenues for the 1st quarter of Year 2017 and 2018 were 3.5% and 3.2% , respectively. Administrative Expenses The selling expenses for the 1st quarter
selling medical equipment 108.10 63.62 Administrative expenses 99.81 104.41 Finance costs 23.47 23.13 Finance costs (net) 21.16 20.58 Proportion of cost of medical treatment / revenue of medical treatment
Thailand Tel. 66-38 480-020-1 FAX. 66-38 480-080 4.2 Investment Proportion (Shareholding Proportion) - Before Investment : : 4,961 ordinary share or 35.44 of registered capital - After Investment : 11,954
398.21 314.81 Administrative expenses 460.64 414.05 Loss from Impairment of Investment 56.89 - Finance costs 61.87 92.81 Finance costs (net) 46.22 83.33 Proportion of cost of medical treatment / revenue of
10 per share. EFORL subscribed its right of Baht 436,499,970. After the first allotment has been completed, as at 31 December 2018, the proportion of shareholding in WCIH of EFORL is 63.7% of paid up
treatment 582.81 568.86 Cost of selling medical equipment 85.44 108.10 Administrative expenses 146.98 99.81 Finance costs 15.27 23.47 Finance costs (net) 12.81 21.16 Proportion of cost of medical treatment
(net) 12.52 20.87 Proportion of cost of medical treatment / revenue of medical treatment 65.01 65.22 Proportion of cost of administrative expenses/revenue of medical treatment 11.53 11.57 It can be seen
equipment 614.09 407.46 Administrative expenses 516.93 486.11 Loss from Impairment of Investment 248.04 56.89 Finance costs 46.17 61.87 Finance costs (net) 32.25 46.22 Proportion of cost of medical treatment